GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin

ABSTRACT: The purpose of this study is to determine the efficacy of an oral investigational drug in patients with refractory metastatic colorectal cancer after receiving prior therapy with 5-fluorouracil in combination with irinotecan and/or oxaliplatin.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2008130 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR